Evidence map›Paper›PMID 30295892›Full record

ArticleMolecular biology and evolution2019

Functional Conservation of a Developmental Switch in Mammals since the Jurassic Age.

Jayati Mookerjee-Basu, Xiang Hua, Lu Ge, Emmanuelle Nicolas, Qin Li, Philip Czyzewicz, Dai Zhongping, Suraj Peri, Juan I FuxmanBass, Albertha J M Walhout and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular biology and evolution, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Jayati Mookerjee-BasuBlood Cell Development and Cancer Program, Fox Chase Cancer Center, Philadelphia, PA.
Xiang HuaBlood Cell Development and Cancer Program, Fox Chase Cancer Center, Philadelphia, PA.
Lu GeBlood Cell Development and Cancer Program, Fox Chase Cancer Center, Philadelphia, PA.
Emmanuelle NicolasBlood Cell Development and Cancer Program, Fox Chase Cancer Center, Philadelphia, PA.
Qin LiBlood Cell Development and Cancer Program, Fox Chase Cancer Center, Philadelphia, PA.
Philip CzyzewiczBlood Cell Development and Cancer Program, Fox Chase Cancer Center, Philadelphia, PA.
Dai ZhongpingBlood Cell Development and Cancer Program, Fox Chase Cancer Center, Philadelphia, PA.
Suraj PeriBlood Cell Development and Cancer Program, Fox Chase Cancer Center, Philadelphia, PA.
Juan I FuxmanBassProgram in Systems Biology, Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA.
Albertha J M WalhoutProgram in Systems Biology, Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA.
Dietmar J KappesBlood Cell Development and Cancer Program, Fox Chase Cancer Center, Philadelphia, PA.
Fox Chase Cancer Center · USUniversity of Massachusetts Chan Medical School · US

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Margaret von Mehren · 1985 to 2026
$138.8M
Identifying transcription factor binding sites in the C. elegans genomeR01GM082971 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WALHOUT, A. J. MARIAN · 2008 to 2016
$5.8M
Transcriptional Control of Th-POK, a Key Regulator of Lineage ControlR01AI068907 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI KAPPES, DIETMAR J · 2008 to 2011
$2.0M
Dissecting the role of ThPOK in thymic development and T cell differentiationR01GM107179 · NIGMS · RESEARCH INST OF FOX CHASE CAN CTR · PI KAPPES, DIETMAR J · 2014 to 2017
$1.4M
NCI NIH HHS P30 CA006927NIAID NIH HHS R01 AI068907NIGMS NIH HHS R01 GM082971NIGMS NIH HHS R01 GM107179
6 · The paper itself

Abstract

ThPOK is a "master regulator" of T lymphocyte lineage choice, whose presence or absence is sufficient to dictate development to the CD4 or CD8 lineages, respectively. Induction of ThPOK is transcriptionally regulated, via a lineage-specific silencer element, SilThPOK. Here, we take advantage of the available genome sequence data as well as site-specific gene targeting technology, to evaluate the functional conservation of ThPOK regulation across mammalian evolution, and assess the importance of motif grammar (order and orientation of TF binding sites) on SilThPOK function in vivo. We make three important points: First, the SilThPOK is present in marsupial and placental mammals, but is not found in available genome assemblies of nonmammalian vertebrates, indicating that it arose after divergence of mammals from other vertebrates. Secondly, by replacing the murine SilThPOK in situ with its marsupial equivalent using a knockin approach, we demonstrate that the marsupial SilThPOK supports correct CD4 T lymphocyte lineage-specification in mice. To our knowledge, this is the first in vivo demonstration of functional equivalency for a silencer element between marsupial and placental mammals using a definitive knockin approach. Finally, we show that alteration of the position/orientation of a highly conserved region within the murine SilThPOK is sufficient to destroy silencer activity in vivo, demonstrating that motif grammar of this "solid" synteny block is critical for silencer function. Dependence of SilThPOK function on motif grammar conserved since the mid-Jurassic age, 165 Ma, suggests that the SilThPOK operates as a silenceosome, by analogy with the previously proposed enhanceosome model.

Indexed as

Biological EvolutionSilencer Elements, TranscriptionalAmino Acid SequenceAnimalsConserved SequenceHumansMiceOpossumsT-LymphocytesTranscription FactorsTranscription FactorsZbtb7b protein, mouse

Identifiers

PMID30295892
PMCPMC6340473
OpenAlexW2897308404

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.